Exos Asset Management’s Evolent Health EVH Stock Holding History

Exos Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,610	Closed	-$55K	–	546
2021 Q2	$55K	Buy	+2,610	New	+$52.3K	0.03%	527

Other funds holding EVH

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Exos Asset Management's EVH Position: Q3 2021 in Review

Exos Asset Management sold out of Evolent Health (EVH) in Q3 2021, closing a stake of 2,610 shares — an estimated $55K sold.

Exos Asset Management first reported a position in EVH in Q2 2021 and held it in 1 quarter. The position peaked at $55K in Q2 2021. 209 funds tracked by Wall St. Rank hold EVH as of Q3 2021.

Exos Asset Management reported no remaining Evolent Health position as of Q3 2021 after selling out during the quarter.
Exos Asset Management sold 2,610 Evolent Health shares in Q3 2021, an estimated $55K.
Exos Asset Management first reported a position in Evolent Health in Q2 2021 and held it in 1 quarter.
Exos Asset Management's Evolent Health position peaked at $55K in Q2 2021.
209 funds tracked by Wall St. Rank held Evolent Health as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.